Arcturus Therapeutics Holdings Inc.

MetLife Investment Management, LLC ARCT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

9,357

Value ($000)

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	57	0.0%	9,357	12/31/2025
2025 Q3	11/13/2025	300	0.0%	16,295	9/30/2025
2025 Q2	8/13/2025	212	0.0%	16,295	6/30/2025
2025 Q1	5/14/2025	173	0.0%	16,295	3/31/2025
2024 Q4	2/13/2025	283	0.0%	16,676	12/31/2024
2024 Q3	11/13/2024	318	0.0%	13,721	9/30/2024
2024 Q2	8/13/2024	334	0.0%	13,721	6/30/2024
2024 Q1	5/14/2024	416	0.0%	12,327	3/31/2024
2023 Q4	4/22/2024	389	0.0%	12,327	12/31/2023
2023 Q3	5/9/2024	315	0.0%	12,327	9/30/2023
2023 Q2	4/29/2024	354	0.0%	12,327	6/30/2023
2023 Q1	5/9/2024	295	0.0%	12,327	3/31/2023
2022 Q4	5/10/2024	209	0.0%	12,327	12/31/2022
2022 Q3	5/10/2024	183	0.0%	12,327	9/30/2022
2022 Q2	5/10/2024	194	0.0%	12,327	6/30/2022
2022 Q1	5/10/2024	332	0.0%	12,327	3/31/2022
2021 Q4	5/17/2024	274	0.0%	7,412	12/31/2021
2021 Q3	5/17/2024	354	0.0%	7,412	9/30/2021
2021 Q2	5/17/2024	302	0.0%	8,939	6/30/2021
2021 Q1	5/17/2024	369	0.0%	8,939	3/31/2021
2020 Q4	5/24/2024	388	0.0%	8,939	12/31/2020
2020 Q3	5/24/2024	304	0.0%	7,084	9/30/2020
2020 Q2	5/24/2024	282	0.0%	6,044	6/30/2020